Illumina has made several management changes in the wake of its acquisition of Solexa last month. John West, the former CEO of Solexa, has joined Illumina as senior vice president and general manager of the sequencing business; John Stuelpnagel, Illumina’s COO, will now also serve as general manager of the company’s microarray business; Tristan Orpin, Illumina’s vice president of sales, has been promoted to senior vice president in charge of all commercial operations; Christian Henry, vice president and CFO, has been promoted to senior vice president and CFO and has assumed the additional responsibility of investor relations; Matt Posard, vice president of marketing, is now vice president of sales; while Omead Ostadan, formerly vice president of marketing at Solexa, will replace Posard as vice president of marketing at Illumina. In addition, Solexa directors Blaine Bowman and Roy Whitfield have joined Illumina’s board.
Former Affymetrix CFO Gregory Schiffman has joined the board of directors of Entelos, the company said last week. Schiffman is CFO at Dendreon. He also was a vice president and controller for Applied Biosystems and a manager at Hewlett Packard and at IBM.
Institute for Systems Biology co-founder Lee Hood will be inducted into the National Inventors Hall of Fame.
Hood is being honored for helping to develop the DNA-sequencing technology that was used in the Human Genome Project.
An awards ceremony featuring Hood and several other inventors will be held May 4-5 in Akron, Ohio. The NIHF annually awards individuals with patented inventions that may be of benefit to society.
Biowisdom has appointed Jack Reynolds as chairman of the board of its safety intelligence program, the company said last week.
He will act as a scientific advisor and will work on the development and implementation of the safety intelligence program.
Reynolds formerly worked at Pfizer as senior vice president of R&D and head of safety sciences and comparative medicine, Biowisdom said.